U.S. Industrial REITs Stock News

More than US$100b in Trump era tariff refunds is starting to wash back through large U.S. importers, quietly reshaping earnings, cash flows, and even consumer pricing power. That mix of extra cash and still firm growth has created fresh openings in some corners of the market, while turning others into potential traps. This article walks through three large cap consumer facing stocks exposed to this news and what that might mean for your portfolio thinking. The stocks in the list below are...

XPO, Inc. announced that Jonas Svedlund joined the company as chief legal officer on August 10, 2026, to lead its legal and compliance, corporate governance and commercial matters after senior roles at Thermo Fisher Scientific, General Electric and law firm Sullivan & Cromwell. His appointment adds large-cap industrial and life sciences legal experience to XPO’s leadership bench at a time when regulatory, contractual and technology issues are increasingly central to freight operations. Next,...

UFP Technologies, Inc. reported past second-quarter 2026 results with sales of US$173.96 million and net income of US$20.85 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. For the first half of 2026, the company showed higher sales and net income than the prior year period, pointing to improved profitability and operating performance across its core business. With stronger year-on-year sales and earnings in both the quarter and...

ConnectOne Bancorp (CNOB) stock is in focus after recent trading data showed mixed short term moves and a stronger longer term record, which gives investors fresh context for assessing this regional bank. See our latest analysis for ConnectOne Bancorp. With the share price at about US$33.03, ConnectOne Bancorp has seen mixed short term trading. The 90 day share price return of 13.64% sits alongside a 26.44% year to date share price return and a 40.83% 1 year total shareholder return, which...

Restructuring playbooks that once sat inside private equity funds are now turning up in listed MedTech groups, with job cuts, asset sales and portfolio reviews all hitting the headlines at the same time as regulatory setbacks and fresh takeover interest. That mix can create sharp winners and quiet laggards. This article walks through three MedTech stocks exposed to these catalysts and explains how investors might think about the risks and potential rewards. The stocks covered in this article...

Novavax (NVAX) is back in focus after its latest quarterly report showed revenue of US$56.7 million and a swing from profit to a net loss, along with a new US$82.5 million shelf registration filing. See our latest analysis for Novavax. The latest results and shelf registration have landed against a mixed backdrop for Novavax, with the 1-day share price return down 1.11% but the year-to-date share price return up 12.90%, while the 1-year total shareholder return has declined 17.10%. If you are...

Bank of Hawaii (BOH) has drawn investor focus after recent trading left the stock at US$80.29. The move comes alongside mixed short term returns, with a gain over the past 3 months but a decline over the past month. See our latest analysis for Bank of Hawaii. Set against a 1-day share price return of 0.54% and a 7-day share price return of 2.03%, Bank of Hawaii’s 30-day share price return of 6.48% is weaker compared with its 17.35% year to date share price return and 28.70% 1-year total...

Permian Basin Royalty Trust (PBT) recently reported second quarter and first half 2026 results, with higher revenue and net income than a year earlier, drawing fresh attention from income focused energy investors. See our latest analysis for Permian Basin Royalty Trust. At a share price of US$32.69, Permian Basin Royalty Trust has seen strong momentum, with an 85.84% year to date share price return and a very large 5 year total shareholder return of 652.56%. The 1 year total shareholder...

Vir Biotechnology, Inc. reported second-quarter 2026 results showing revenue of US$238.95 million versus US$1.21 million a year earlier, with net income of US$80.08 million replacing a net loss of US$110.96 million and earnings per share from continuing operations turning to US$0.48 basic and US$0.47 diluted. Over the first half of 2026, revenue rose to US$238.92 million from US$4.25 million, while the company reduced its net loss to US$45.62 million and sharply improved loss per share,...

Powell Industries earnings and acquisition plans set the stage Powell Industries (POWL) has drawn fresh attention after reporting third quarter and year to date results, along with comments about an active acquisition pipeline focused on expanding services and complementary products. See our latest analysis for Powell Industries. At a share price of US$213.48, Powell Industries has experienced short term share price pressure over the past month and quarter. However, its year to date share...

American States Water Company reported past second-quarter 2026 results showing sales and revenue of US$181.29 million and net income of US$43.27 million, all higher than a year earlier, with diluted EPS from continuing operations at US$1.09 versus US$0.87. These results also lifted performance for the first half of 2026, with revenue up to US$350.48 million and net income at US$73.22 million, underscoring improving profitability across the period. With this step-up in quarterly earnings now...

OneMain Holdings (OMF) recently completed two senior unsecured fixed income offerings totaling US$1.1b in notes due 2034, including 7.125% notes, a funding move that reshapes its debt profile and long term interest obligations. See our latest analysis for OneMain Holdings. Against this refinancing backdrop, OneMain Holdings’ recent share price momentum has been positive, with a 30 day share price return of 8.92% and a 90 day return of 24.16%, while the year to date share price return has...

Capricor Therapeutics (CAPR) is back in focus after reporting second quarter 2026 results and wider losses, alongside ongoing legal and regulatory questions around its lead Duchenne muscular dystrophy candidate, Deramiocel. See our latest analysis for Capricor Therapeutics. The latest Q2 loss and ongoing Deramiocel scrutiny have come alongside sharp volatility in Capricor Therapeutics’ stock, with the share price jumping 58% in the last day and 73% over seven days, yet still down strongly...

J. M. Smucker stock has delivered a solid 25.6% year to date return, yet the company currently screens as overvalued on market multiples and scores poorly on broader valuation checks. For investors, that raises the question of whether the recent share price strength has already priced in much of the good news. J. M. Smucker is up 25.6% year to date, which points to a strong rebound in sentiment after a mixed few years of returns. Future pricing power and brand strength can support the...

Liberty Energy stock has delivered a strong run over the past few years, yet current valuation checks suggest the shares are not a straightforward bargain. The market has rewarded holders, while the broader metrics now point to a more mixed picture on price versus fundamentals. Over the last 5 years Liberty Energy has returned 134.2%, which sets a high bar for any further gains to be supported by fundamentals. Future cash generation from Liberty Energy's operations can support the current...

MDU Resources Group (MDU) just caught investor attention after its board approved a higher quarterly dividend and reset its long term payout target, following recent earnings and guidance updates. See our latest analysis for MDU Resources Group. The dividend increase and reaffirmed earnings guidance come after a mixed price stretch for MDU Resources Group, with the latest share price at $20.65 and recent short term weakness contrasting with stronger long term total shareholder returns. The...

Inspire Medical Systems stock has endured a steep share price decline over the past three years, yet the current intrinsic value checks, including a Discounted Cash Flow (DCF) estimate, point to a company that screens as undervalued relative to where the market is pricing it today. The share price is down 73.8% over three years, which means current buyers are assessing a very different risk and return profile than investors who bought at earlier highs. The DCF estimate indicates the stock...

Global bond yields are seeing some of the strongest upward pressure in over a decade, with 10 year yields in key markets sitting at multi year highs. That has put management teams and analysts under the spotlight, since funding costs and growth expectations now matter more to valuations. This article highlights three fast growing stocks with high insider ownership that align with that backdrop and that may be worth a closer look. The stocks highlighted below are only a small sample, with the...

In August 2026, Tripadvisor, Inc. reported second-quarter 2026 results showing sales of US$441.9 million and net income of US$22.4 million, both lower than the same period a year earlier, alongside weaker performance for the first half of the year. This softer top- and bottom-line performance raises questions about how effectively Tripadvisor’s investments in areas like experiences, AI, and new B2B offerings are translating into financial progress. Next, we will examine how this softer...

The United States market has experienced a stable week, maintaining its position after a significant 20% increase over the past year, with earnings projected to grow by 17% annually. In this environment, identifying stocks that are potentially undervalued and show insider activity can be an intriguing strategy for investors seeking opportunities in the small-cap sector.

Over the last 7 days, the United States market has remained flat, yet over the past year, it has seen a notable rise of 20%, with earnings projected to grow by 17% annually in the coming years. In this environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between current stock prices and their intrinsic value.

In the last week, the United States market has stayed flat, but it is up 20% over the past year with earnings forecast to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders.

In the last week, the United States market has stayed flat, yet it has experienced a 20% increase over the past year with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying lesser-known stocks that demonstrate strong fundamentals and growth potential can be key to enhancing your portfolio.

Over the last 7 days, the United States market has remained flat, yet it has experienced a 20% increase over the past year with earnings projected to grow by 17% annually in the coming years. In this context, reliable dividend stocks that offer substantial yields can be an attractive option for investors seeking consistent income and potential growth amidst stable market conditions.